Morning Overview on MSN
Single-cell breakthrough decodes transcriptome, epigenome & 3D genome at once
A team led by Professor Inkyung Jung from the Department of Biological Sciences at KAIST, working with Professor Yarui Diao’s group, has published a new single-cell method called scHiCAR that ...
Background High serum levels of interleukin 6 (IL-6) predict poor prognosis in intrahepatic cholangiocarcinoma (iCCA), a malignancy that often develops in a chronically inflamed milieu . Here, tumour ...
Caris Life Sciences reports another breakthrough study for GPSai in identifying and correcting misdiagnosis of cancer patients: Irving, Texas Monday, March 23, 2026, 16:00 Hrs [IS ...
These misdiagnoses carry direc and life-altering clinical consequences, as treatment recommendations and prognostic ...
Rinzimetostat is a potent and highly selective next-generation allosteric PRC2 inhibitor targeting the EED subunit that has demonstrated potential best-in-class efficacy and safety in a dose ...
A study published in Stem Cell Reports demonstrates that genetically engineered human pluripotent stem cells (hPSCs) can overcome immune rejection in mice with humanized immune systems, surviving for ...
Neurodegenerative diseases affect more than 57 million people globally. The incidence of these diseases, from Alzheimer's to Parkinson's to ALS and beyond, is expected to double every 20 years. Though ...
XCells Biotechnologies USA, Inc. ("iXCells"), a leading provider of human cell-based solutions and custom iPSC services, today announced the delivery of over 500 characterized induced pluripotent stem ...
The evidence supporting the conclusions of this work is solid, and ANTIPODE presents an updated methodological approach to determining how gene expression at the cell-type level has evolved. Thus, ...
Japan’s health ministry has endorsed issuing conditional approval for two first-of-a-kind medicines. But some researchers say that the therapies — made from reprogrammed stem cells and called Amchepry ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results